Turn back the clock and be healed induced pluripotent stem cells and their future impact on drug discovery and regenerative medicine

European Pharmaceutical Review

Volumn , Issue 2, 2010, Pages

  Andrews, Paul D ^a  

^a UNIVERSITY OF DUNDEE   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ACTIVIN; ENZYME; KRUPPEL LIKE FACTOR 4; LENTIVIRUS VECTOR; LIN28 PROTEIN; MITOGEN ACTIVATED PROTEIN KINASE; MYC PROTEIN; OCTAMER TRANSCRIPTION FACTOR 4; PLASMID VECTOR; RETROVIRUS VECTOR; TRANSCRIPTION FACTOR NANOG; TRANSCRIPTION FACTOR SOX2; TRANSFORMING GROWTH FACTOR BETA; UNCLASSIFIED DRUG; VALPROIC ACID;

ALZHEIMER DISEASE; AMYOTROPHIC LATERAL SCLEROSIS; BLASTOCYST; CELL DIFFERENTIATION; CELL DIVISION; CELL FUSION; CELL HYPOXIA; CELL NUCLEUS; CELL NUCLEUS TRANSPLANTATION; CELL REGENERATION; CELL RENEWAL; CELL TRANSPLANTATION; CHROMATIN STRUCTURE; CISTRON; CYTOLOGY; DNA MODIFICATION; DRUG RESEARCH; EMBRYONIC STEM CELL; EPIGENETICS; FIBROBLAST; GENE EXPRESSION; GENE OVEREXPRESSION; GENETIC TRANSCRIPTION; GENETIC TRANSFECTION; GENETIC VARIABILITY; HUMAN; MEDICAL ETHICS; MODEL; MOLECULAR BIOLOGY; PARKINSON DISEASE; PLURIPOTENT STEM CELL; PREDICTION; PRENATAL DIAGNOSIS; REGENERATIVE MEDICINE; REVIEW; SIGNAL TRANSDUCTION; SPINAL MUSCULAR ATROPHY; STEM CELL; TISSUE REPAIR; TOTIPOTENT STEM CELL; TOXICOLOGY; TRANSPOSON; XENOPUS LAEVIS;

IPS;

EID: 77953437003     PISSN: 13608606     EISSN: None     Source Type: Trade Journal    
DOI: None     Document Type: Review

References (52)

1. Gurdon, J.B., Adult frogs derived from the nuclei of single somatic cells. Dev Biol, 1962. 4: p. 256-273
2. Blau, H.M., C.P. Chiu, and C. Webster, Cyto plasmic activation of human nuclear genes in stable heterocaryons. Cell, 1983. 32 (4): p. 1171-1180
3. Tada, M., et al., Nuclear reprogramming of somatic cells by in vitro hybridization with ES cells. Curr Biol, 2001. 11(19): p. 1553-1558
4. Do, J.T. and H.R. Scholer, Nuclei of embryonic stem cells reprogram somatic cells. Stem Cells, 2004. 22(6): p. 941-949
5. Cowan, C.A., et al., Nuclear reprogramming of somatic cells after fusion with human embryonic stem cells. Science, 2005. 309(5739): p. 1369-1373
6. Wilmut, I., et al., Viable offspring derived from fetal and adult mammalian cells. Nature, 1997. 385(6619): p. 810-813
7. Takahashi, K. and S. Yamanaka, Induction of pluripotent stem cells from mouse embryonic and adult fibroblast cultures by defined factors. Cell, 2006. 126(4): p. 663-676
8. Takahashi, K., et al., Induction of pluripotent stem cells from adult human fibroblasts by defined factors. Cell, 2007. 131(5): p. 861-872
9. Okita, K., T. Ichisaka, and S. Yamanaka, Generation of germline -competent induced pluripotent stem cells. Nature, 2007. 448 (7151): p. 313-317
10. Yu, J., et al., Induced pluripotent stem cell lines derived from human somatic cells. Science, 2007. 318(5858): p. 1917-1920
11. Wernig, M., et al., c-Myc is dispensable for direct reprogramming of mouse fibroblasts. Cell Stem Cell, 2008. 2(1): p. 10-12
12. Park, I.H., et al., Reprogramming of human somatic cells to pluripotency with defined factors. Nature, 2008. 451(7175): p. 141-146
13. Feng, B., et al., Reprogramming of fibroblasts into induced pluripotent stem cells with orphan nuclear receptor Esrrb. Nat Cell Biol, 2009. 11(2): p. 197-203.
14. Nakagawa, M., et al., Generation of induced pluripotent stem cells without Myc from mouse and human fibroblasts. Nat Biotechnol, 2008. 26(1): p. 101-106
15. Heng, J.-C.D., et al., The nuclear receptor Nr5a2 can replace Oct4 in the reprogramming of murine somatic cells to pluripotent cells. Cell Stem Cell, 2010. 6(2): p. 167-174
16. Judson, R.L., et al., Embryonic stem cell-specific microRNAs promote induced pluripotency. Nat Biotechnol, 2009. 27(5): p. 459-461
17. Gunaratne, P.H., Embryonic stem cell microRNAs: defining factors in induced pluripotent (iPS) and cancer (CSC) stem cells? Curr Stem Cell Res Ther, 2009. 4(3): p. 168-177
18. Viswanathan, S.R. and G.Q. Daley, Lin28: A microRNA regulator with a macro role. Cell, 2010. 140(4): p. 445-449
19. Soldner, F., et al., Parkinson's disease patientderived induced pluripotent stem cells free of viral reprogramming factors. Cell, 2009. 136(5): p. 964-977
20. Kaji, K., et al., Virus-free induction of pluripotency and subsequent excision of reprogramming factors. Nature, 2009. 458(7239): p. 771-775
21. Woltjen, K., et al., piggyBac transposition reprograms fibroblasts to induced pluripotent stem cells. Nature, 2009. 458(7239): p. 766-770
22. Yu, J., et al., Human induced pluripotent stem cells free of vector and transgene sequences. Science, 2009. 324(5928): p. 797-801.
23. Gonzalez, F., et al., Generation of mouse-induced pluripotent stem cells by transient expression of a single nonviral polycistronic vector. Proc Natl Acad Sci USA, 2009. 106(22): p. 8918-8922
24. Papapetrou, E.P., et al., Stoichiometric and temporal requirements of Oct4, Sox2, Klf4, and c-Myc expression for efficient human iPSC induction and differentiation. Proc Natl Acad Sci USA, 2009. 106(31): p. 12759-12764
25. Okita, K., et al., Generation of mouse induced pluripotent stem cells without viral vectors. Science, 2008. 322(5903): p. 949-953
26. Okita, K., et al., Generation of mouse-induced pluripotent stem cells with plasmid vectors. Nat Protoc, 2010. 5(3): p. 418-428
27. Zhou, H., et al., Generation of induced pluripotent stem cells using recombinant proteins. Cell Stem Cell, 2009. 4(5): p. 381-384
28. Kim, D., et al., Generation of human induced pluripotent stem cells by direct delivery of reprogramming proteins. Cell Stem Cell, 2009. 4(6): p. 472-476
29. Andrews, P.D. and J.A.F. Frearson, Influencing Stem Cell Fate with Small Molecules. European Pharmaceutical Review Digital, 2009. 1: p. 18-28.
30. Feng, B., et al., Molecules that promote or enhance reprogramming of somatic cells to induced pluripotent stem cells. Cell Stem Cell, 2009. 4(4): p. 301-312
31. Ichida, J.K., et al., A small-molecule inhibitor of tgf-Beta signaling replaces sox2 in re programming by inducing nanog. Cell Stem Cell, 2009. 5(5): p. 491-503.
32. Maherali, N. and K. Hochedlinger, Tgfbeta signal inhibition cooperates in the induction of iPSCs and replaces Sox2 and cMyc. Curr Biol, 2009. 19(20): p. 1718-1723
33. Lin, T., et al., A chemical platform for improved induction of human iPSCs. Nat Meth, 2009. 6(11): p. 805-808
34. Yoshida, Y., et al., Hypoxia enhances the generation of induced pluripotent stem cells. Cell Stem Cell, 2009. 5(3): p. 237-241
35. Esteban, M.A., et al., Vitamin C enhances the generation of mouse and human induced pluripotent stem cells. Cell Stem Cell, 2010. 6(1): p. 71-79
36. Utikal, J., et al., Immortalization eliminates a roadblock during cellular reprogramming into iPS cells. Nature, 2009. 460(7259): p. 1145-1148
37. Li, H., et al., The Ink4/Arf locus is a barrier for iPS cell reprogramming. Nature, 2009. 460(7259): p. 1136-1139
38. Marión, R.M., et al., A p53-mediated DNA damage response limits reprogramming to ensure iPS cell genomic integrity. Nature, 2009. 460(7259): p. 1149-1153
39. Kawamura, T., et al., Linking the p53 tumour suppressor pathway to somatic cell reprogramming. Nature, 2009. 460 (7259): p. 1140-1144
40. Banito, A., et al., Senescence impairs successful reprogramming to pluripotent stem cells. Genes & Development, 2009. 23(18): p. 2134-2139
41. Hanna, J., et al., Direct cell reprogramming is a stochastic process amenable to acceleration. Nature, 2009. 462(7273): p. 595-601.
42. Eminli, S., et al., Differentiation stage determines potential of hematopoietic cells for reprogramming into induced pluripotent stem cells. Nat Genet, 2009. 41(9): p. 968-976
43. Urbach, A., M. Schuldiner, and N. Benvenisty, Modeling for Lesch-Nyhan disease by gene targeting in human embryonic stem cells. Stem cells (Dayton, Ohio), 2004. 22(4): p. 635-641 (Pubitemid 39014579)
44. Mateizel, I., et al., Derivation of human embryonic stem cell lines from embryos obtained after IVF and after PGD for monogenic disorders. Hum Reprod, 2006. 21(2): p. 503-511
45. Pickering, S.J., et al., Generation of a human embryonic stem cell line encoding the cystic fibrosis mutation deltaF508, using preimplantation genetic diagnosis. Reprod Biomed Online, 2005. 10(3): p. 390-397
46. Eiges, R., et al., Developmental study of fragile X syndrome using human embryonic stem cells derived from preimplantation genetically diagnosed embryos. Cell Stem Cell, 2007. 1(5): p. 568-577
47. Ebert, A.D., et al., Induced pluripotent stem cells from a spinal muscular atrophy patient. Nature, 2009. 457(7227): p. 277-280
48. Dimos, J.T., et al., Induced pluripotent stem cells generated from patients with ALS can be differentiated into motor neurons. Science, 2008. 321(5893): p. 1218-1221
49. Park, I.H., et al., Disease-specific induced pluripotent stem cells. Cell, 2008. 134(5): p. 877-886
50. Di Giorgio, F.P. and K. Eggan, Non-cell autonomous effect of glia on motor neurons in an embryonic stem cell-based ALS model. 2007. 10(5): p. 608-614
51. Di Giorgio, F.P., Human embryonic stem cell-derived motor neurons are sensitive to the toxic effect of glial cells carrying an ALS-causing mutation. Cell Stem Cell, 2008. 3(6): p. 637-648
52. Raya, A., et al., A protocol describing the genetic correction of somatic human cells and subsequent generation of iPS cells. Nat Protoc, 2010. 5(4): p. 647-660